Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications multinational drug utilisation study investigate use dexmedetomidine dexdor�� clinical 1
… story Disease burden Unmet needs Value of the product (clinical, humanistic, economic ) Market access strategy … Objection Handlers Objection handlers are for reactive use when your teams are challenged by payers and need to … Provider Perspective What is the best possible treatment? Clinical Trial Results How will the product influence the …
… 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Share on: Friday, … will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Treatment patterns … early stage NSCLC: interim analysis of a global real-world study. Lin SH, Ahn M, Nagar S, Affi R, Agulnik J, Shih J, …
… C, Koffman B, Manzoor BS, Biondo J, Mansfield C. Poster Clinical burden of β-Thalassemia: findings from a multinational medical record abstraction study. Cappellini MD, Yucel A, Meyers J, Jimenez M, Nham T, …
… Joint Clinical Assessment Support Get Ready for Your 100-Day Sprint … now will be in the best position when the EU Joint Clinical Assessment launches in January of 2025. RTI-HS can …
… Are Companies Responding to Expected Challenges with Joint Clinical Assessments? Share on: September 10, 2024 Image … Data Analytics and Design Strategy RTI Health Solutions Drug manufacturers are preparing to navigate joint clinical assessment (JCA) in several ways. On one hand, …
… Africa. She has extensive experience coordinating multinational study teams and expertise in reproductive health epidemiology, drug utilization studies, vaccine safety, and external …
… and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.” While its title suggests … be considered when evaluating PROs intended to support drug submissions as well as medical devices. The draft offers … differences between the population in the pivotal clinical study (e.g., stage of disease) and the population that …
… E. Transcript As part of a postauthorization safety study sponsored by AstraZeneca, we evaluated cardiovascular safety endpoints related to the use of aclidinium. The study evaluated the risk of acute … years or older initiating the study medications in the UK Clinical Practice Research Datalink between 2012 and 2019. …
… outcomes (PROs) and are a major focus of ongoing drug development. The US Food and Drug Administration (FDA) strongly encourages the use of PROs in clinical trials to accurately assess treatment benefits. …
… VAC4EU , the Vaccine Monitoring Collaboration for Europe study network, we are helping to increase the availability of …